[Federal Register Volume 85, Number 21 (Friday, January 31, 2020)]
[Notices]
[Page 5670]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-01809]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Meeting of the CDC/HRSA Advisory Committee on HIV, Viral
Hepatitis and STD Prevention and Treatment
AGENCY: Health Resources and Services Administration (HRSA), Department
of Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, this
notice announces that the Centers for Disease Control and Prevention
(CDC)/HRSA Advisory Committee on HIV, Viral Hepatitis and STD
Prevention and Treatment (CHAC) has scheduled a public meeting.
Information about CHAC can be found at https://www.cdc.gov/maso/facm/facmCHACHSPT.html.
DATES: March 5, 2020, 3:00 p.m.--4:00 p.m. Eastern Time (ET).
ADDRESSES: This meeting will be held by webinar and will accommodate up
to 100 attendees. To access the virtual meeting, please use the
information below.
Webinar link: https://hrsa.connectsolutions.com/chac_business_meeting/
Conference call-in number:
[cir] Call in: 888-790-1964.
[cir] Passcode: 1251991.
FOR FURTHER INFORMATION CONTACT: Theresa Jumento, Public Health
Advisor, HIV/AIDS Bureau, HRSA, 5600 Fishers Lane, Rockville, Maryland
20857; 301-443-5807; or [email protected].
SUPPLEMENTARY INFORMATION: CHAC was established under Section 222 of
the Public Health Service (PHS) Act, [42 U.S.C. Section 217a], as
amended.
The purpose of CHAC is to advise the Secretary of HHS, the Director
of CDC, and the HRSA Administrator regarding objectives, strategies,
policies, and priorities for HIV, viral hepatitis, and other STDs;
prevention and treatment efforts including surveillance of HIV
infection, viral hepatitis, other STDs, and related behaviors;
epidemiologic, behavioral, health services, and laboratory research on
HIV, viral hepatitis, and other STDs; identification of policy issues
related to HIV/viral hepatitis/STD professional eduction, patient
healthcare delivery, and prevention services; agency policies about
prevention of HIV, viral hepatitis and other STDs; treatment,
healthcare delivery, and research and training; strategic issues
influencing the ability of CDC and HRSA to fulfill their missions of
providing prevention and treatment services; programmatic efforts to
prevent and treat HIV, viral hepatitis, and other STDs; and support to
the agencies in their developoment of responses to emerging health
needs related to HIV, viral hepatitis, and other STDs.
During the March 5, 2020, meeting, CHAC will discuss issues related
to a CDC pilot on recency assay-based incidence estimation and the
President's initiative on ``Ending the HIV Epidemic: A Plan for
America.'' Agenda items are subject to change as priorities dictate.
Due to the nature and time limitations of the meeting, members of
the public will not have an opportunity to provide oral comments,
although written comments may be submitted prior to the meeting, or up
to 5 business days after the meeting, to Theresa Jumento at the contact
information listed above. Individuals who plan to attend and need
special assistance or another reasonable accommodation should notify
Theresa Jumento at the address and phone number listed above at least
10 business days prior to the meeting.
Maria G. Button,
Director, Division of the Executive Secretariat.
[FR Doc. 2020-01809 Filed 1-30-20; 8:45 am]
BILLING CODE 4165-15-P